• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Nimesulide spectrophotometric determination in the visible region].

作者信息

Perju Andreia Claudia, Mândrescu Mariana, Spac A F, Dorneanu V

机构信息

Facultatea de Farmacie, Disciplina de Chimie analitică, Universitatea de Medicină i Farmacie "Gr.T. Popa" Iaşi.

出版信息

Rev Med Chir Soc Med Nat Iasi. 2007 Apr-Jun;111(2):535-9.

PMID:17983199
Abstract

UNLABELLED

Nimesulide is a nonsteroidal antiinflammatory (NSAID) drug whose mechanism of action is characterized by selective inhibition of cyclooxygenase-2. Nimesulide have analgesic and antipyretic properties.

MATERIALS AND METHOD

For nimesulide analysis we developed a spectrophotometric method based on reduction of the nitro group of nimesulide by zinc and hydrochloric acid followed by diazotization and coupling with thymol (5-methyl-2-(1-methylethyl) phenol) in ammonia medium to form a stable chromophore which absorbs at 476 nm. There were established the practical working conditions. The developed method was validated.

RESULTS

The method showed a good linearity in the range of 5 - 40 microg / sample (the correlation coefficient r = 0.9990). The detection limit (LD) was 0.99 microg/sample and the quantification limit (LQ) was 3.32 microg/sample. There were established the system precision (RSD = 1.70%), the precision (RSD < 2.2%) and the accuracy (recovery in the range 97.66 - 102.69% with a mean recovery of 99.81%) of the method.

CONCLUSIONS

A new method for nimesulide spectrophotometric quantification in visible has been developed.

摘要

相似文献

1
[Nimesulide spectrophotometric determination in the visible region].
Rev Med Chir Soc Med Nat Iasi. 2007 Apr-Jun;111(2):535-9.
2
[Nimesulide: a lower risk treatment in rheumatic diseases].尼美舒利:风湿性疾病中风险较低的治疗药物
Vnitr Lek. 2004 Feb;50(2):157-62.
3
Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus.尼美舒利——一种针对炎症和疼痛的多因素治疗方法:科学与临床共识。
Curr Med Res Opin. 2006 Jun;22(6):1161-70. doi: 10.1185/030079906X104849.
4
Improved high-performance liquid chromatographic assay for nimesulide.尼美舒利的改进型高效液相色谱测定法
J Chromatogr B Biomed Sci Appl. 1999 Feb 19;723(1-2):293-9. doi: 10.1016/s0378-4347(98)00559-3.
5
Tramadol pharmacokinetics and its possible interactions with cyclooxygenase 2-selective nonsteroidal anti-inflammatory drugs.曲马多的药代动力学及其与环氧化酶-2选择性非甾体抗炎药的可能相互作用。
Clin Pharmacol Ther. 2004 Apr;75(4):363-5. doi: 10.1016/j.clpt.2003.12.011.
6
Partition and location of nimesulide in EPC liposomes: a spectrophotometric and fluorescence study.尼美舒利在EPC脂质体中的分配与定位:分光光度法和荧光研究
Anal Bioanal Chem. 2003 Sep;377(2):293-8. doi: 10.1007/s00216-003-2089-5. Epub 2003 Jul 25.
7
Quantification of infant exposure to celecoxib through breast milk.婴儿通过母乳接触塞来昔布的定量分析。
Br J Clin Pharmacol. 2006 Jan;61(1):101-4. doi: 10.1111/j.1365-2125.2005.02520.x.
8
Tolerability of nimesulide in aspirin-sensitive patients.尼美舒利在阿司匹林敏感患者中的耐受性
Ann Allergy. 1994 Jan;72(1):29-32.
9
Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide.选择性环氧化酶-2非甾体抗炎药尼美舒利的治疗用途及作用的现状
Inflammopharmacology. 2006 Aug;14(3-4):120-37. doi: 10.1007/s10787-006-1505-9.
10
Novel coupling reagents for the sensitive spectrophotometric determination of nimesulide in pharmaceutical preparations.用于分光光度法灵敏测定药物制剂中尼美舒利的新型偶联试剂。
J Pharm Biomed Anal. 2002 Jun 20;29(1-2):277-82. doi: 10.1016/s0731-7085(02)00060-2.